Carcinogenesis Advance Access originally published online on September 26, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Carcinogenesis, Vol. 25, No. 1, 21-28,
January 2004
© Oxford University Press; all rights reserved
CANCER BIOLOGY |
Opposed arsenite-induced signaling pathways promote cell proliferation or apoptosis in cultured lung cells
1 Institute of Molecular Biology, 2 Open Laboratory of Chemical Biology of the Institute of Molecular Technology for Drug Discovery and Synthesis and 3 Department of Chemistry, The University of Hong Kong, Hong Kong SAR, China, 4 Department of Medicine, University of Vermont College of Medicine, Burlington, VT 05405, USA and 5 Department of Cell Biology, University of Massachusetts Medical Center, Worcester, MA 01655, USA
Arsenic is a well-known carcinogen that possibly promotes tumors and the development of various types of cancer in individuals chronically exposed to arsenic in their work or living environment. Many studies have demonstrated the activation of mitogen-activated protein kinase (MAPK) in several cell types by using lethal concentrations of arsenic in the range of 50–500 µM. Since the exposure of humans to arsenic is normally at a much lower level in the workplace or in daily life, it is more relevant to study the effects of arsenic at this lower exposure level. In the present study we aimed at redefining the role of signal transduction pathways in arsenic-induced malignant transformation as well as apoptosis using our established in vitro rat lung epithelial cell model system. Our results indicate a molecular mechanism by which MAPK pathways might differentially contribute to cell growth regulation and cell death in response to different dosages of arsenite. A low level (2 µM) of arsenite stimulated extracellular signal-regulated kinase (ERK) signaling pathway and enhanced cell proliferation, and this arsenite-induced ERK activity was blocked by MEK inhibitor, PD98059. In contrast, a high level (40 µM) of arsenite stimulated the c-Jun N-terminal kinase (JNK) signaling pathway and induced cell apoptosis, and this arsenite-induced JNK activity was blocked by JNK inhibitor II, SP600125. The implications of these findings are that a high concentration of arsenic exposure causes apoptosis, whereas a low concentration of arsenic exposure is carcinogenic and may result in aberrant cell accumulation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  C. E. Olsen, A. E. Liguori, Y. Zong, R. C. Lantz, J. L. Burgess, and S. Boitano Arsenic upregulates MMP-9 and inhibits wound repair in human airway epithelial cells Am J Physiol Lung Cell Mol Physiol, August 1, 2008; 295(2): L293 - L302. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Andrew, V. Bernardo, L. A. Warnke, J. C. Davey, T. Hampton, R. A. Mason, J. E. Thorpe, M. A. Ihnat, and J. W. Hamilton Exposure to Arsenic at Levels Found in U.S. Drinking Water Modifies Expression in the Mouse Lung Toxicol. Sci., November 1, 2007; 100(1): 75 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-Y. Chai, Y.-C. Huang, W.-C. Hung, W.-Y. Kang, and W.-T. Chen Arsenic salt-induced DNA damage and expression of mutant p53 and COX-2 proteins in SV-40 immortalized human uroepithelial cells Mutagenesis, November 1, 2007; 22(6): 403 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Mousa, L. O'Connor, T. G. Rossman, and E. Block Pro-angiogenesis action of arsenic and its reversal by selenium-derived compounds Carcinogenesis, May 1, 2007; 28(5): 962 - 967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. T.Y. Lau and J.-F. Chiu The Possible Role of Cytokeratin 8 in Cadmium-Induced Adaptation and Carcinogenesis Cancer Res., March 1, 2007; 67(5): 2107 - 2113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Zhang, L. Song, J. Li, K. Wu, and C. Huang Coordination of JNK1 and JNK2 Is Critical for GADD45{alpha} Induction and Its Mediated Cell Apoptosis in Arsenite Responses J. Biol. Chem., November 10, 2006; 281(45): 34113 - 34123. [Abstract] [Full Text] [PDF]
|
|